{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:24:12Z","timestamp":1792686252515,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 824"],"award-info":[{"award-number":["SFB 824"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander Foundation","doi-asserted-by":"publisher","award":["2021.094.1"],"award-info":[{"award-number":["2021.094.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"German Cancer Aid","doi-asserted-by":"publisher","award":["70114896"],"award-info":[{"award-number":["70114896"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.10.033","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:08:12Z","timestamp":1760803692000},"page":"6130-6145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["TGF-\u03b21-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs"],"prefix":"10.1016","volume":"33","author":[{"given":"Yang","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria F.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nagarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin A.","family":"Schmohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Stauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Spellerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Kitzberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Kumbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang A.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle I.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-9697","authenticated-orcid":false,"given":"Christine","family":"Spitzweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.033_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ymthe.2025.10.033_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2213-8587(14)70051-8","article-title":"Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets","volume":"2","author":"Spitzweg","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ymthe.2025.10.033_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/er.2012-1036","article-title":"The Na+\/I- symporter (NIS): mechanism and medical impact","volume":"35","author":"Portulano","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymthe.2025.10.033_bib4","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jcem.86.7.7641","article-title":"Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy","volume":"86","author":"Spitzweg","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.10.033_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/erc.1.01119","article-title":"The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane","volume":"13","author":"Riesco-Eizaguirre","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"Fagin","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.033_bib7","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","article-title":"Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers","volume":"24","author":"Pozdeyev","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib8","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.10.033_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.033_bib10","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1158\/0008-5472.CAN-09-1248","article-title":"The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer","volume":"69","author":"Riesco-Eizaguirre","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib11","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1074\/jbc.M307138200","article-title":"The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium\/iodide symporter gene","volume":"279","author":"Costamagna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.10.033_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-2007-978946","article-title":"Expression of transforming growth factor-\u03b21 and transforming growth factor-\u03b2 type-II receptor mRNA in papillary thyroid carcinoma","volume":"30","author":"Matoba","year":"1998","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/thy.1999.9.119","article-title":"Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study","volume":"9","author":"Kimura","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.ymthe.2025.10.033_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yexcr.2014.06.012","article-title":"Mutual regulation of TGF-beta1, TbetaRII and ErbB receptors expression in human thyroid carcinomas","volume":"327","author":"Mincione","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13277-013-1053-z","article-title":"Notch and TGF-beta\/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ymthe.2025.10.033_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massague","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2025.10.033_bib17","doi-asserted-by":"crossref","first-page":"12173","DOI":"10.1002\/jcp.27955","article-title":"Transforming growth factor-beta signaling: Tumorigenesis and targeting for cancer therapy","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ymthe.2025.10.033_bib18","first-page":"3457","article-title":"Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers","volume":"49","author":"Colletta","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1089\/thy.1997.7.789","article-title":"Transforming growth factor-beta1 suppresses thyrotropin-induced Na+\/I- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells","volume":"7","author":"Kawaguchi","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ymthe.2025.10.033_bib20","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/onc.2011.44","article-title":"Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling","volume":"30","author":"Knauf","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.10.033_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/ERC-21-0017","article-title":"Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers","volume":"28","author":"Luckett","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib22","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.033_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/14712598.2016.1196179","article-title":"Harnessing mesenchymal stem cell homing as an anticancer therapy","volume":"16","author":"Hagenhoff","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/mt.2011.93","article-title":"Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery","volume":"19","author":"Knoop","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/SLA.0b013e3182368c4f","article-title":"Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma","volume":"254","author":"Niess","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ymthe.2025.10.033_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/SLA.0b013e3181fcb5d8","article-title":"Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis","volume":"253","author":"Conrad","year":"2011","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ymthe.2025.10.033_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/SLA.0b013e3181bd62d0","article-title":"Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma","volume":"250","author":"Zischek","year":"2009","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ymthe.2025.10.033_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/156652307781369119","article-title":"Genetically engineered stem cells for therapeutic gene delivery","volume":"7","author":"Conrad","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib29","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/ijc.32230","article-title":"Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1\/2 TREAT-ME-1 trial","volume":"145","author":"von Einem","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib30","doi-asserted-by":"crossref","first-page":"80156","DOI":"10.18632\/oncotarget.20964","article-title":"Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial","volume":"8","author":"von Einem","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.10.033_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12885-015-1241-x","article-title":"Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I\/II clinical trial","volume":"15","author":"Niess","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41419-025-07443-0","article-title":"Engineered mesenchymal stem\/stromal cells against cancer","volume":"16","author":"Shi","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2025.10.033_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13550-022-00888-w","article-title":"The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy","volume":"12","author":"Kitzberger","year":"2022","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.omto.2023.08.004","article-title":"Interleukin-6-controlled, mesenchymal stem cell-based sodium\/iodide symporter gene therapy improves survival of glioblastoma-bearing mice","volume":"30","author":"Kitzberger","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.10.033_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-22-1433","article-title":"Mesenchymal Stem Cell-mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice","volume":"29","author":"Kitzberger","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/hum.2012.104","article-title":"Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma","volume":"24","author":"Knoop","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2967\/jnumed.114.146662","article-title":"Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene","volume":"56","author":"Knoop","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ymthe.2025.10.033_bib38","doi-asserted-by":"crossref","first-page":"54795","DOI":"10.18632\/oncotarget.10758","article-title":"Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery","volume":"7","author":"Muller","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2025.10.033_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/1541-7786.MCR-18-0185","article-title":"A Novel Approach for Image-Guided (131)I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery","volume":"17","author":"Schug","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib40","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1158\/1078-0432.CCR-18-4092","article-title":"Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene (131)I Therapy","volume":"25","author":"Schug","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/hum.2018.025","article-title":"External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene Delivery","volume":"29","author":"Schug","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/ERC-18-0173","article-title":"TGFB1-driven mesenchymal stem cell-mediated NIS gene transfer","volume":"26","author":"Schug","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ymthe.2020.10.009","article-title":"Regional Hyperthermia Enhances Mesenchymal Stem Cell Recruitment to Tumor Stroma: Implications for Mesenchymal Stem Cell-Based Tumor Therapy","volume":"29","author":"Tutter","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib44","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.7150\/thno.41489","article-title":"Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells","volume":"10","author":"Tutter","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.10.033_bib45","doi-asserted-by":"crossref","first-page":"T193","DOI":"10.1530\/ERC-21-0177","article-title":"The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment","volume":"28","author":"Spitzweg","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/scd.2005.14.329","article-title":"Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4","volume":"14","author":"Von Luttichau","year":"2005","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.ymthe.2025.10.033_bib47","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/jc.2007-0402","article-title":"Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression","volume":"92","author":"Willhauck","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.10.033_bib48","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00259-008-0775-4","article-title":"The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer","volume":"35","author":"Willhauck","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ymthe.2025.10.033_bib49","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1089\/hum.2010.158","article-title":"Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery","volume":"22","author":"Klutz","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib50","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","article-title":"Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies","volume":"25","author":"Landa","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/146532401317070871","article-title":"Highly efficient retroviral gene transfer into immortalized CD34(-) cells and organ distribution after transplantation into NOD\/SCID mice","volume":"3","author":"Thalmeier","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymthe.2025.10.033_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep34365","article-title":"A vector platform for the rapid and efficient engineering of stable complex transgenes","volume":"6","author":"Jackel","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.10.033_bib53","first-page":"2136","article-title":"Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines","volume":"59","author":"Spitzweg","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.033_bib54","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1530\/ERC-15-0245","article-title":"Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin alphavbeta3","volume":"22","author":"Schmohl","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.033_bib55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00428-020-02983-6","article-title":"Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer","volume":"478","author":"Michl","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.ymthe.2025.10.033_bib56","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2007.081","article-title":"Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression","volume":"18","author":"Spitzweg","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.10.033_bib57","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/mt.2016.95","article-title":"Sequence-defined cMET\/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene","volume":"24","author":"Urnauer","year":"2016","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:07:03Z","timestamp":1778616423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625008548"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.033","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TGF-\u03b21-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}